Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Credit agrmnt [a]
Acq. announced
|
|
Tribute Pharmaceuticals Canada Inc. (TBUFF)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/09/2015 |
8-K
| Quarterly results|
Docs:
|
"Tribute Announces Third Quarter 2015 Results -Revenue Up 133%, EBITDA Up 281% over Comparative Period- MILTON, ONTARIO – November 9, 2015 - Tribute Pharmaceuticals Canada Inc. , a diversified healthcare company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., today announced its operational and financial results for the third quarter ended September 30, 2015. Unless otherwise indicated, all dollar amounts included herein are stated in Canadian dollars. The Company's financial statements and management report are available at www.sedar.com, www.sec.gov and at www.tributepharma.com. Financial Results Highlights Three Months Ended September 30, 2015 Nine Months Ended September 30, 2015 Total Revenues $9,007,850 $21,02..." |
|
| 08/17/2015 |
8-K
| Quarterly results|
Docs:
|
"Tribute Pharmaceuticals Announces Second Quarter 2015 Results -Revenue Up 59%, Gross Profit Up 101% over Comparative Period- MILTON, ONTARIO – August 17, 2015 - Tribute Pharmaceuticals Canada Inc. , a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., today announced its operational and financial results for the second quarter ended June 30, 2015. Unless otherwise indicated, all dollar amounts included herein are stated in Canadian dollars. The Company's financial statements and management report are available at www.sedar.com, www.sec.gov and at www.tributepharma.com. Financial Results Highlights Three Months Ended Six Months Ended June 30, 2015 Total Revenues $ 6,429,500 $ 12,021,8..." |
|
| 05/14/2015 |
8-K
| Quarterly results|
Docs:
|
"Tribute Pharmaceuticals Announces First Quarter 2015 Results -Revenue Up 60%, EBITDA Up 116% Over Comparative Period- MILTON, ONTARIO – May 12, 2015 - Tribute Pharmaceuticals Canada Inc. , a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., today announced its operational and financial results for the first quarter ended March 31, 2015. Unless otherwise indicated, all dollar amounts included herein are stated in Canadian dollars. The Company's financial statements and management report are available at www.sedar.com, www.sec.gov and at www.tributepharma.com. Financial Results Highlights Three Months Ended March 31, 2015 Three Months Ended March 31, 2014 Revenue $ 5,592,297 $ 3,493,55..." |
|
| 11/10/2014 |
8-K
| Quarterly results|
Docs:
|
"Tribute Pharmaceuticals Reports Double Digit Revenue Growth in Third Quarter 2014 MILTON, ONTARIO - - Tribute Pharmaceuticals Canada Inc. , a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the US, today announced financial results for its third quarter ending September 30, 2014. In this press release, all dollar amounts are expressed in Canadian currency - unless otherwise noted - and results are reported in accordance with United States generally accepted accounting principles . On October 2, 2014, subsequent to the quarter ended September 30, 2014, the Company entered into an asset purchase agreement, license agreement and supply agreement with Novartis AG and Novartis Pharma AG pursuant..." |
|
| 11/29/2013 |
8-K/A
| Quarterly results |
| 11/14/2013 |
8-K
| Quarterly results |
| 03/21/2013 |
8-K
| Form 8-K - Current report |
| 05/15/2012 |
8-K
| Form 8-K - Current report |
| 04/02/2012 |
8-K
| Quarterly results |
| 11/21/2011 |
8-K
| Form 8-K - Current report |
| 08/15/2011 |
8-K
| Quarterly results |
| 05/16/2011 |
8-K
| Form 8-K - Current report |
| 03/31/2011 |
8-K
| Form 8-K - Current report |
| 11/10/2010 |
8-K
| Form 8-K - Current report |
| 05/14/2010 |
8-K
| Form 8-K - Current report |
| 11/10/2009 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/06/2009 |
8-K
| Form 8-K - Current report |
| 06/04/2009 |
8-K
| Form 8-K - Current report |
| 05/15/2007 |
8-K
| Form 8-K - Current report |
| 11/09/2006 |
8-K
| Form 8-K - Current report |
| 08/10/2006 |
8-K
| Form 8-K - Current report |
| 03/31/2006 |
8-K
| Form 8-K - Current report |
| 01/13/2006 |
8-K
| Form 8-K - Current report |
| 01/13/2006 |
8-K
| Form 8-K - Current report |
| 01/13/2006 |
8-K
| Form 8-K - Current report |
| 01/13/2006 |
8-K
| Form 8-K - Current report |
|
|